The NIH has awarded OMRF scientist Matlock Jeffries $874,000 to launch an innovative study of the origin and progression of OA.
paper
Bodywork: Pressing pause on a coronavirus vaccine trial
Last week, the drug company AstraZeneca halted its SARS-CoV-2 vaccine trial. What happened?
OMRF researchers identify genes that may cause cancer to recur after treatment
Cancer often returns after successful therapy, but why?
Oklahoma researchers zero in on cause of blood disorder
New findings could help scientists develop treatments for the condition known as ITP.
Blood test identifies people at high risk for lupus
New research will help physicians better identify blood relatives of lupus patients at risk for developing the disease.
Researchers make new insights into birth defects, infertility
Abnormal numbers of chromosomes—known as aneuploidy—are a common cause of genetic disorders and birth defects.
